As of Nov 2, 2026, QGEN's PEG ratio of 1.93 reflects its valuation relative to its growth. This value reflects a P/E ratio of 26.09 measured against EPS growth of 13.5%. When compared to the trailing four-quarter average of 0.42, QGEN's PEG ratio shows a 357% increase.
Qiagen's nine years historical PEG ratio has an average of 2.64. Compared to historical data, QGEN's 1.93 PE to growth ratio represents a decline of 27%. QGEN reached its maximum PEG ratio of 18.6 during the Sep 2018 quarter over the past nine years. The Jun 2021 quarter had the bottom reading at 0.01, indicating the most optimal growth-adjusted valuation.
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 0.06 | 22.94 | 415.8% |
| 2024 | N/A | 117.18 | -74.7% |
| 2023 | N/A | 29.85 | -19.4% |
| 2022 | N/A | 27.64 | -17.3% |
| 2021 | 0.65 | 25.47 | 38.9% |
| 2020 | 0.04 | 33.63 | 952.6% |
| 2019 | N/A | N/A | -121.8% |
| 2018 | 0.11 | 40.82 | 357.9% |
| 2017 | N/A | 167.83 | -45.7% |
| 2016 | N/A | 85.71 | -39.7% |
| 2015 | 4.44 | 51.04 | 11.5% |
| 2014 | 0.77 | 48.3 | 62.5% |
| 2013 | N/A | 79.66 | -45.8% |
| 2012 | 0.97 | 32.93 | 34.1% |
| 2011 | N/A | 33.6 | -33.3% |
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Jun 2026 | 1.5 | 20.26 | 13.5% |
| Mar 2026 | 0.06 | 21.41 | 334.9% |
| Dec 2025 | 0.06 | 22.94 | 415.8% |
| Sep 2025 | 0.07 | 24.02 | 365% |
| Jun 2025 | 0.06 | 28.27 | 466.7% |
| Mar 2025 | N/A | 93.37 | -70.9% |
| Dec 2024 | N/A | 117.18 | -74.7% |
| Sep 2024 | N/A | 113.93 | -71.4% |
| Jun 2024 | N/A | 136.97 | -79% |
| Mar 2024 | N/A | 29.05 | -2% |
| Dec 2023 | N/A | 29.85 | -19.4% |
| Sep 2023 | N/A | 29.82 | -30.7% |
| Jun 2023 | N/A | 32.46 | -36.4% |
| Mar 2023 | N/A | 31.36 | -36.3% |
| Dec 2022 | N/A | 27.64 | -17.3% |
Measured against past performance, QGEN's PEG ratio is higher than its 3 and 5-year averages, though it is below the 10-year average.
With a PEG of 1.93, QGEN is above the Healthcare sector and the industry average. Compared to its Healthcare sector average of 0.71, Qiagen's PEG is 172% higher.
Compared to its peers, QGEN's PEG ratio is under GE's and TMO's but above TECH's.
According to Nov 2, 2026 data, QGEN's PEG ratio sits at 1.93.
QGEN has a 3-year average PEG ratio of 0.35.
QGEN has a 5-year average PEG ratio of 1.31.
QGEN's PEG ratio peaked at 18.6 during the Sep 2018 quarter - the highest in nine years.
Currently, QGEN's PEG ratio stands 27% lower than its 9-year historical average.
To calculate the PEG ratio, take the company's PE ratio and divide by its EPS growth (YoY TTM). As of Nov 2, 2026, Qiagen has a P/E ratio of 26.09. Earnings grew at 13.5% over the TTM period ending Jun 2026. Applying the formula, this produces a price to earnings growth ratio of 1.93. PEG RATIO(1.93) = PE RATIO(26.09) / EPS GROWTH(13.5%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.